-
1
المؤلفون: Krop, I, Maguire, P, Lahti-Domenici, J, Lodeiro, G, Richardson, A, Johannsdottir, HK, Nevanlinna, H, Borg, Åke, Gelman, R, Barkardottir, RB, Lindblom, A, Polyak, K
المصدر: Cancer Research. 63(9):2024-2027
مصطلحات موضوعية: Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology
URL الوصول: https://lup.lub.lu.se/record/312186
http://cancerres.aacrjournals.org/cgi/content/abstract/63/9/2024 -
2
المؤلفون: Johannsdottir, HK, Johannesdottir, G, Agnarsson, BA, Eerola, H, Arason, A, Johannsson, OT, Heikkila, P, Egilsson, V, Olsson, Håkan, Borg, Åke, Nevanlinna, H, Barkardottir, RB
المصدر: Anticancer research. 24(5A):2681-2687
مصطلحات موضوعية: BRCA2, breast cancer, BRCA1, loss of heterozygosity, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology
URL الوصول: https://lup.lub.lu.se/record/262953
-
3
المؤلفون: Rozenblum, E, Vahteristo, P, Törngren, Therese, Bergthorsson, JT, Syrjakoski, K, Weaver, D, Haraldsson, Karin, Johannsdottir, HK, Vehmanen, P, Nigam, S, Golberger, N, Robbins, C, Pak, E, Dutra, A, Gillander, E, Stephan, DA, Bailey-Wilson, J, Juo, SHH, Kainu, T, Arason, A, Barkardottir, RB, Nevanlinna, H, Borg, Åke, Kallioniemi, OP
المصدر: Human Genetics. 110(2):111-121
-
4دورية أكاديمية
المؤلفون: Novello S; Department of Oncology, University of Turin, Turin, Italy., Mazières J; Department of Pneumology, Toulouse University Hospital, Paul Sabatier University, Toulouse, France., Oh IJ; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun Jeollanam-do, Republic of Korea., de Castro J; Department of Translational Oncology, La Paz University Hospital, Madrid, Spain., Migliorino MR; Azienda Ospedaliera San Camillo Forlanini Hospital, Rome, Italy., Helland Å; Department of Cancer Genetics and Department of Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Dziadziuszko R; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Griesinger F; Department of Hematology and Oncology, Pius Hospital, Medical Campus University of Oldenburg, Oldenburg, Germany., Kotb A; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Zeaiter A; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Cardona A; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Balas B; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Johannsdottir HK; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Das-Gupta A; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Wolf J; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de.
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Jun 01; Vol. 29 (6), pp. 1409-1416.
نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Salvage Therapy*, Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Central Nervous System Neoplasms/*drug therapy , Drug Resistance, Neoplasm/*drug effects , Lung Neoplasms/*drug therapy, Adenocarcinoma/secondary ; Adult ; Aged ; Aged, 80 and over ; Carbazoles/administration & dosage ; Carcinoma, Non-Small-Cell Lung/pathology ; Central Nervous System Neoplasms/secondary ; Crizotinib/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/pathology ; Lymphatic Metastasis ; Male ; Middle Aged ; Pemetrexed/administration & dosage ; Piperidines/administration & dosage ; Prognosis ; Survival Rate
-
5دورية أكاديمية
المؤلفون: Ciuleanu T; Institute of Oncology Ion Chiricuta, Cluj-Napoca, Romania. tudor@iocn.ro, Stelmakh L, Cicenas S, Miliauskas S, Grigorescu AC, Hillenbach C, Johannsdottir HK, Klughammer B, Gonzalez EE
المصدر: The Lancet. Oncology [Lancet Oncol] 2012 Mar; Vol. 13 (3), pp. 300-8. Date of Electronic Publication: 2012 Jan 24.
نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , Quinazolines/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Non-Small-Cell Lung/enzymology ; Carcinoma, Non-Small-Cell Lung/secondary ; Chi-Square Distribution ; Docetaxel ; Early Termination of Clinical Trials ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Erlotinib Hydrochloride ; Europe ; Female ; Glutamates/administration & dosage ; Guanine/administration & dosage ; Guanine/analogs & derivatives ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Lung Neoplasms/enzymology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Pemetrexed ; Prospective Studies ; Protein Kinase Inhibitors/adverse effects ; Quinazolines/adverse effects ; Salvage Therapy ; Taxoids/administration & dosage ; Time Factors ; Treatment Outcome
-
6دورية أكاديمية
المؤلفون: Johannsdottir HK; Institute of Biochemistry, ETH Zurich, Schafmattstrasse 18, CH-8093 Zurich, Switzerland., Mancini R, Kartenbeck J, Amato L, Helenius A
المصدر: Journal of virology [J Virol] 2009 Jan; Vol. 83 (1), pp. 440-53. Date of Electronic Publication: 2008 Oct 29.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
مواضيع طبية MeSH: Virus Internalization*, Vesiculovirus/*physiology, Adaptor Protein Complex 2/antagonists & inhibitors ; Adaptor Protein Complex 2/metabolism ; Clathrin/antagonists & inhibitors ; Clathrin/metabolism ; Dynamin II/antagonists & inhibitors ; Dynamin II/metabolism ; Endocytosis ; Endosomes/virology ; Epithelial Cells/ultrastructure ; Epithelial Cells/virology ; HeLa Cells ; Humans ; Microscopy, Electron, Transmission ; Microscopy, Video ; Time Factors
-
7دورية أكاديمية
المؤلفون: Johannsdottir HK; Department of Pathology, Landspitali-University Hospital, Reykjavik, Iceland., Jonsson G, Johannesdottir G, Agnarsson BA, Eerola H, Arason A, Heikkila P, Egilsson V, Olsson H, Johannsson OT, Nevanlinna H, Borg A, Barkardottir RB
المصدر: International journal of cancer [Int J Cancer] 2006 Sep 01; Vol. 119 (5), pp. 1052-60.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Print ISSN: 0020-7136 (Print) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Chromosome Mapping* , Chromosomes, Human, Pair 5* , Genes, BRCA1* , Genes, BRCA2* , Germ-Line Mutation* , Loss of Heterozygosity*, Breast Neoplasms/*genetics, Adult ; Aged ; Allelic Imbalance ; Breast Neoplasms/pathology ; Female ; Gene Deletion ; Heterozygote ; Humans ; Middle Aged ; Polymerase Chain Reaction